 |
MorphoSys AG
MOR
|
1.28 |
- |
2.43 % |
$ 254 M |
Germany |
 |
Aligos Therapeutics
ALGS
|
1.23 |
$ 8.97 |
2.87 % |
$ 88.7 M |
USA |
 |
Alterity Therapeutics Limited
ATHE
|
125 |
$ 3.66 |
- |
$ 8.81 B |
Australia |
 |
Allakos
ALLK
|
0.674 |
- |
- |
$ 28.6 M |
USA |
 |
Aptinyx
APTX
|
0.248 |
- |
-39.0 % |
$ 4.57 M |
USA |
 |
Aravive
ARAV
|
5.67 |
- |
-13.39 % |
$ 1.45 M |
USA |
 |
Anavex Life Sciences Corp.
AVXL
|
3.07 |
$ 3.21 |
3.05 % |
$ 274 M |
USA |
 |
I-Mab
IMAB
|
1.12 |
- |
- |
$ 866 M |
China |
 |
AlloVir
ALVR
|
-0.258 |
- |
4.14 % |
$ 49.1 M |
USA |
 |
Applied Molecular Transport
AMTI
|
0.364 |
- |
- |
$ 10.1 M |
USA |
 |
Alexion Pharmaceuticals, Inc.
ALXN
|
2.88 |
- |
- |
$ 40.3 B |
USA |
 |
Genfit SA
GNFT
|
596 |
- |
2.54 % |
$ 160 B |
France |
 |
Biophytis SA
BPTS
|
15.7 |
- |
-13.47 % |
$ 169 M |
France |
 |
Brainstorm Cell Therapeutics
BCLI
|
-0.815 |
- |
-2.5 % |
$ 5.88 M |
USA |
 |
Applied Therapeutics
APLT
|
-31.5 |
- |
- |
$ 8.42 M |
USA |
 |
EyeGate Pharmaceuticals, Inc.
EYEG
|
4.13 |
- |
-1.52 % |
$ 24.7 M |
USA |
 |
BeiGene, Ltd.
BGNE
|
75.9 |
- |
0.49 % |
$ 251 B |
Cayman-islands |
 |
bluebird bio
BLUE
|
0.344 |
- |
- |
$ 546 M |
USA |
 |
BioNTech SE
BNTX
|
5.29 |
$ 95.59 |
-1.15 % |
$ 27.2 B |
Germany |
 |
Midatech Pharma plc
MTP
|
7.56 |
- |
-18.52 % |
$ 27.3 M |
Britain |
 |
Burford Capital Limited
BUR
|
1.26 |
$ 4.68 |
4.23 % |
$ 746 M |
Britain |
 |
Cabaletta Bio
CABA
|
2.53 |
$ 3.27 |
2.19 % |
$ 329 M |
USA |
 |
Amphastar Pharmaceuticals
AMPH
|
1.58 |
$ 21.46 |
0.47 % |
$ 1 B |
USA |
 |
Checkpoint Therapeutics
CKPT
|
-12.7 |
- |
- |
$ 169 M |
USA |
 |
Институт стволовых клеток человека
ISKJ
|
6.81 |
- |
- |
- |
Russia |
 |
Adverum Biotechnologies
ADVM
|
1.08 |
- |
- |
$ 86.2 M |
USA |
 |
Advaxis
ADXS
|
0.113 |
- |
-9.65 % |
$ 45.9 M |
USA |
 |
Clearside Biomedical
CLSD
|
-6.37 |
- |
- |
$ 25.3 M |
USA |
 |
Aeterna Zentaris
AEZS
|
0.781 |
- |
5.93 % |
$ 314 M |
Canada |
 |
AgeX Therapeutics
AGE
|
0.00262 |
- |
-10.17 % |
$ 12.2 K |
USA |
 |
Aeglea BioTherapeutics
AGLE
|
1.4 |
- |
- |
$ 1.01 B |
USA |
 |
Akebia Therapeutics
AKBA
|
10.3 |
$ 1.49 |
1.35 % |
$ 383 M |
USA |
 |
Applied Genetic Technologies Corporation
AGTC
|
0.382 |
- |
- |
$ 26.5 M |
USA |
 |
Can-Fite BioPharma Ltd.
CANF
|
32 |
$ 3.03 |
3.77 % |
$ 4.99 M |
Israel |
 |
Aquestive Therapeutics
AQST
|
-13.9 |
$ 4.19 |
- |
$ 448 M |
USA |
 |
Arcutis Biotherapeutics
ARQT
|
18.2 |
$ 24.98 |
3.55 % |
$ 3.18 B |
USA |
 |
Chimerix
CMRX
|
0.537 |
- |
- |
$ 756 M |
USA |
 |
Concert Pharmaceuticals
CNCE
|
0.92 |
- |
- |
$ 401 M |
USA |
 |
AIkido Pharma
AIKI
|
0.492 |
- |
1.93 % |
$ 17.4 M |
USA |
 |
Celldex Therapeutics
CLDX
|
3.87 |
$ 32.74 |
0.46 % |
$ 2.17 B |
USA |
 |
Autolus Therapeutics plc
AUTL
|
1.81 |
$ 1.48 |
0.46 % |
$ 394 M |
Britain |
 |
Aptose Biosciences
APTO
|
-0.511 |
- |
-45.71 % |
$ 1.2 M |
Canada |
 |
Cidara Therapeutics
CDTX
|
0.908 |
- |
- |
$ 1.41 B |
USA |
 |
AVROBIO
AVRO
|
0.594 |
- |
1083.1 % |
$ 745 M |
USA |
 |
CNS Pharmaceuticals
CNSP
|
0.234 |
$ 2.44 |
-2.99 % |
$ 1.08 M |
USA |
 |
Ayala Pharmaceuticals
AYLA
|
0.994 |
- |
- |
$ 7.46 M |
Israel |
 |
AstraZeneca PLC
AZN
|
2.07 |
- |
- |
$ 96.9 B |
Britain |
 |
Akero Therapeutics
AKRO
|
4.34 |
- |
- |
$ 3.67 B |
USA |
 |
CTI BioPharma Corp.
CTIC
|
-31.3 |
- |
- |
$ 1.2 B |
USA |
 |
CureVac N.V.
CVAC
|
5.13 |
- |
- |
$ 867 M |
Germany |